Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Funke-Chambour

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Respiratory Research|January 12, 2018
Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis - a potential biomarker role for LysoPCBarbara Rindlisbacher, Cornelia Schmid, Thomas Geiser, et al.
BMJ Open Respiratory Research|June 4, 2026
BAL lymphocytosis as a predictive marker for drug response and long-term outcome in fibrotic ILD: systematic reviewPhilipp Suter, Annina E Buechi, Zayne Milena Roa-Diaz, et al.
Thorax|April 3, 2026
Challenging the status quo for therapeutic clinical trials in fibrotic interstitial lung diseasesTejaswini Kulkarni, Manuela Funke-Chambour, Steve Jones, et al.
Trends in Molecular Medicine|September 16, 2023
Pulmonary fibrosis: from pathogenesis to clinical decision-makingThomas Koudstaal, Manuela Funke-Chambour, Michael Kreuter, et al.
Swiss Medical Weekly|June 2, 2016
Multidisciplinary discussion for diagnosis of interstitial lung disease in real lifeSabina Anna Guler, Sabina Anna Berezowska, Andreas Christe, et al.
Swiss Medical Weekly|January 30, 2018
Idiopathic pulmonary fibrosis in a Swiss interstitial lung disease reference centreSabina Guler, Pascal Zumstein, Sabina Berezowska, et al.
ERJ Open Research|January 19, 2023
Reply to: Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluationManuela Funke-Chambour, Namrata Kewalramani, Carlos Machahua, et al.
Emerging Infectious Diseases|February 24, 2021
Autochthonous Case of Pulmonary Histoplasmosis, SwitzerlandYvonne Schmiedel, Annina E Büchi, Sabina Berezowska, et al.
ERJ Open Research|June 24, 2022
Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challengesNamrata Kewalramani, Carlos Machahua, Venerino Poletti, et al.
European Radiology|December 29, 2020
Imaging in the aftermath of COVID-19: what to expectLukas Ebner, Manuela Funke-Chambour, Christophe von Garnier, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Respiratory Research|January 12, 2018
Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis - a potential biomarker role for LysoPCBarbara Rindlisbacher, Cornelia Schmid, Thomas Geiser, et al.
BMJ Open Respiratory Research|June 4, 2026
BAL lymphocytosis as a predictive marker for drug response and long-term outcome in fibrotic ILD: systematic reviewPhilipp Suter, Annina E Buechi, Zayne Milena Roa-Diaz, et al.
Thorax|April 3, 2026
Challenging the status quo for therapeutic clinical trials in fibrotic interstitial lung diseasesTejaswini Kulkarni, Manuela Funke-Chambour, Steve Jones, et al.
Trends in Molecular Medicine|September 16, 2023
Pulmonary fibrosis: from pathogenesis to clinical decision-makingThomas Koudstaal, Manuela Funke-Chambour, Michael Kreuter, et al.
Swiss Medical Weekly|June 2, 2016
Multidisciplinary discussion for diagnosis of interstitial lung disease in real lifeSabina Anna Guler, Sabina Anna Berezowska, Andreas Christe, et al.
Swiss Medical Weekly|January 30, 2018
Idiopathic pulmonary fibrosis in a Swiss interstitial lung disease reference centreSabina Guler, Pascal Zumstein, Sabina Berezowska, et al.
ERJ Open Research|January 19, 2023
Reply to: Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluationManuela Funke-Chambour, Namrata Kewalramani, Carlos Machahua, et al.
Emerging Infectious Diseases|February 24, 2021
Autochthonous Case of Pulmonary Histoplasmosis, SwitzerlandYvonne Schmiedel, Annina E Büchi, Sabina Berezowska, et al.
ERJ Open Research|June 24, 2022
Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challengesNamrata Kewalramani, Carlos Machahua, Venerino Poletti, et al.
European Radiology|December 29, 2020
Imaging in the aftermath of COVID-19: what to expectLukas Ebner, Manuela Funke-Chambour, Christophe von Garnier, et al.
Pageof 7